Evaluation of dexmedetomidine in reducing postoperative ocular pain

Evaluation of the effectiveness of Dexmedetomidine in the assessment of postoperative pain in extra ocular muscle surgery in patients with strabismus

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200503047291N1

Enrollment

Registered

2020-08-01

Start date

2019-09-23

Completion date

Unknown

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Strabismus. Condition 2: Esotropia. Condition 3: Exotropia. Unspecified strabismus Unspecified esotropia Exotropia

Interventions

Intervention 1: Intervention group: In this group, 30 patients with inclusion criteria who need the strabismus surgery according to strabismus surgical protocols with specific standards, were randomly

Eligibility

Sex/Gender

All

Age

7 Years to No maximum

Inclusion criteria

Inclusion criteria: Children over 7 years No other medical problems No history of surgery or manipulation of the extraocular muscles strabismus candidate for extra ocular muscle surgery

Exclusion criteria

Exclusion criteria: Patients with drug abuse presence of liver,heart or renal disease unable to answer questions of checklist

Design outcomes

Primary

Measure	Time frame
The amount of postoperative pain. Timepoint: In the designated hours, 4 hours, 8 hours, 12 hours, 24 hours, 48 hours of surgery, the patient's pain rate was assessed using VAS (Visual analogue scale). Method of measurement: Visual Analogue Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamed Hosseinikhahmanshadi

Mashhad University of Medical Sciences

hamed.hosseinikhah@gmail.com+98 51 3844 0459

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026